BUTALBITAL AND ACETAMINOPHEN
Active substance: ACETAMINOPHEN, BUTALBITAL
TABLET · ACETAMINOPHEN 300 mg/1, BUTALBITAL 50 mg/1
United StatesActive
Marketing holder: Aarkish Pharmaceuticals NJ Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
Composition
- ACETAMINOPHEN · 300 mg/1
- BUTALBITAL · 50 mg/1
Registration
- Registration number
- 81005-123
- Registration status
- Active
- Dispensing
- Prescription only
- Control marker
- CIII
- Route
- ORAL
Sources
- product · openFDA NDC · 81005-123 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 81005-123 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 81005-123 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 81005-123 · Verified 2026-10-09 · open in source